Literature DB >> 30951188

Letter to the Editor: Proton Pump Inhibitors in Cirrhosis: A Marker of Morbid Conditions or a Cause of Mortality?

Andrew M Moon1, Paul H Hayashi1, A Sidney Barritt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30951188      PMCID： PMC6679775          DOI： 10.1002/hep.30642

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  3 in total

Review 1.  Proton Pump Inhibitors: Review of Emerging Concerns.

Authors:  Avinash K Nehra; Jeffrey A Alexander; Conor G Loftus; Vandana Nehra
Journal:  Mayo Clin Proc       Date:  2018-02       Impact factor: 7.616

2.  Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.

Authors:  Silvia Nardelli; Stefania Gioia; Lorenzo Ridola; Alessio Farcomeni; Manuela Merli; Oliviero Riggio
Journal:  Hepatology       Date:  2019-03-04       Impact factor: 17.425

3.  Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.

Authors:  Frederik Hvid-Jensen; Rikke B Nielsen; Lars Pedersen; Peter Funch-Jensen; Asbjørn Mohr Drewes; Finn B Larsen; Reimar W Thomsen
Journal:  Clin Epidemiol       Date:  2013-12-04       Impact factor: 4.790
  3 in total
  1 in total

1.  Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial.

Authors:  Ansgar W Lohse; Johannes Kluwe; Malte H Wehmeyer; Thomas Horvatits; Anika Buchholz; Linda Krause; Sarah Walter; Antonia Zapf
Journal:  Trials       Date:  2022-04-12       Impact factor: 2.279
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.